United States Diagnostics & Research news

18:35 29 Jul 2026

globenewswire.com Regulatory and legal Main company 🇺🇸 United States

TUESDAY DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Grail Class Action Lawsuit - GRAL

SAN DIEGO, July 29, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of GRAIL, Inc. (NASDAQ: GRAL) common stock between May 13, 2025 and February 19, 2026, both dates inclusive (the “Class Period”), …

GRAL main company

Sharemaestro market context Price above Trend Line 52 weeks +98.2% · Next-week setup positive 61.9%

18:16 29 Jul 2026

MarketWatch Market update Main company 🇺🇸 United States

Charles River Laboratories International Inc. stock underperforms Wednesday when compared to competitors

Charles River Laboratories International Inc. (CRL) stock dropped 2.34% on Wednesday, closing at $234.80. This underperformance occurred on a generally poor trading day where both the S&P 500 and Dow Jones Industrial Average also saw significant declines. The company's shares finished 3.27% below its …

CRL main company

Sharemaestro market context Trend signal active 52 weeks +73.0%

18:11 29 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

TOVX|Theriva Biologics Inc|Price:0.217|Chg%:-0.002

This article provides a comprehensive stock analysis of Theriva Biologics Inc (TOVX) from TradingKey. It details the company's strong fundamentals, significant growth potential, and fair valuation within the Biotechnology & Medical Research industry. The analysis also highlights high institutional ownership and recent "Buy" ratings …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

18:09 29 Jul 2026

R&D World Earnings Provider-linked mention 🇺🇸 United States

As AI floods drug discovery with designs, Twist uses DNA chips to tackle the wet-lab bottleneck

As artificial intelligence rapidly generates numerous drug designs, particularly in antibody discovery, Twist Bioscience is leveraging its DNA synthesis technology on silicon chips to address the subsequent "wet-lab bottleneck." The company's CEO, Emily Leproust, highlights how AI has significantly increased the volume of candidate …

TWST mentioned

Sharemaestro market context Trend signal active 52 weeks +314.7%

17:38 29 Jul 2026

Investing.com Earnings Provider-linked mention 🇺🇸 United States

Labcorp earnings ahead: Can specialty tests sustain momentum?

Labcorp is set to report its second-quarter earnings, with analysts expecting significant year-over-year growth in both earnings per share and revenue. Investors will be closely watching the performance of its specialty testing portfolio in oncology, women's health, neurology, and autoimmune disease, as well as …

LH mentioned

Sharemaestro market context Trend signal active 52 weeks +15.6%

16:40 29 Jul 2026

TradingKey Market update Main company 🇺🇸 United States

Precipio Inc (PRPO) Institutional Confidence

This article analyzes the institutional confidence score for Precipio Inc (PRPO), which stands at 3.00, ranking 130 out of 199 in its industry. The institutional shareholding proportion is 19.15%, showing a slight decrease. James Simons is identified as the largest institutional shareholder, with other …

PRPO main company

Sharemaestro market context Price below Trend Line 52 weeks +64.8% · Next-week setup positive 55.7%

16:38 29 Jul 2026

The Globe and Mail Earnings Provider-linked mention 🇺🇸 United States

Zimmer Biomet Set to Report Q2 Earnings: What's in the Cards?

Zimmer Biomet (ZBH) is expected to report its second-quarter 2026 earnings on August 5th, with revenue estimates of $2.13 billion and EPS of $2.01. The company's performance is anticipated to be driven by strong demand in its Knees, Hips, S.E.T (Sports Medicine, Upper Extremities, …

LH mentioned

Sharemaestro market context Trend signal active 52 weeks +15.6%

16:37 29 Jul 2026

GlobeNewswire Regulatory and legal Main company 🇺🇸 United States

WGS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

Faruqi & Faruqi, LLP is reminding investors of the August 3, 2026, deadline to seek lead plaintiff status in a federal securities class action lawsuit against GeneDx Holdings Corp. (NASDAQ: WGS). The lawsuit alleges that GeneDx and its executives made misleading statements regarding the …

WGS main company

Sharemaestro market context Price above Trend Line 52 weeks -39.3%

16:09 29 Jul 2026

Sahm Earnings Main company 🇺🇸 United States

NeoGenomics (NEO) Stock Rallies As Profit Returns And Margins Improve

NeoGenomics (NEO) stock rallied by 14% after reporting a swing from a Q1 loss to a modest Q2 profit, driven by improved margins and increased average price per test. While clinical revenue and NGS growth are strong, concerns remain regarding the decline in pharma …

NEO main company

Sharemaestro market context Trend signal active 52 weeks +141.3% · Next-week setup negative 40.8%

16:07 29 Jul 2026

Market source Earnings Main company 🇺🇸 United States

IQVIA Holdings Inc (IQV) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and AI-Driven ...

IQVIA Holdings Inc. (IQV) reported strong Q2 2026 results, exceeding guidance for revenue, adjusted EBITDA, and adjusted diluted EPS. The company saw accelerated organic growth and significant increases in R&D Solutions net new bookings, driven by AI-enabled capabilities and increased outsourcing in the pharmaceutical …

IQV main company

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

16:01 29 Jul 2026

MarketBeat Earnings Main company 🇺🇸 United States

Biodesix (BDSX) to Post Earnings on Wednesday

Biodesix (BDSX) is scheduled to release its Q2 2026 earnings after market close on Wednesday, August 5th. Analysts anticipate a loss of $0.86 per share on revenue of approximately $26.03 million. In the previous quarter, the company surpassed estimates by reporting a loss of …

BDSX main company

Sharemaestro market context Trend signal active 52 weeks +164.7% · Next-week setup negative 43.8%

15:10 29 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

MGNX|MacroGenics Inc|Price:3.732|Chg%:+0.062

This article provides a comprehensive stock analysis of MacroGenics Inc (MGNX) from TradingKey, highlighting its strong fundamentals, high growth potential, and "fairly valued" status. Despite recent market weakness, the company's revenue and net income have seen significant growth, and analysts have issued "Buy" ratings …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

14:39 29 Jul 2026

TradingView Earnings Provider-linked mention 🇺🇸 United States

WM Earnings Beat on Pricing in Q2, Revenues Miss Estimates

Waste Management (WM) reported stronger-than-expected adjusted earnings for Q2 2026, driven by disciplined pricing and operating efficiencies, despite revenues slightly missing estimates. The company saw a 5.2% increase in earnings year-over-year and a 4% rise in revenues. While core price increased and EBITDA margin …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

14:39 29 Jul 2026

globenewswire.com Regulatory and legal Main company 🇺🇸 United States

GRAIL, INC. INVESTORS WITH LOSSES HAVE UNTIL AUGUST 4, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds GRAIL, Inc. (“GRAIL” or the “Company”) (NASDAQ: GRAL) investors of the August 4, 2026 deadline involving a securities fraud class action lawsuit commenced against the …

GRAL main company

Sharemaestro market context Price above Trend Line 52 weeks +98.2% · Next-week setup positive 61.9%

14:38 29 Jul 2026

www.marketscreener.com Analyst action Main company 🇺🇸 United States

Jefferies Adjusts IQVIA Holdings Price Target to $290 From $220, Maintains Buy Rating

Jefferies has increased its price target for IQVIA Holdings (IQV) shares to $290, up from $220, while reiterating a Buy rating on the stock. This adjustment reflects a positive outlook on the biopharmaceutical services company's future performance. Several other analysts have also updated their …

IQV main company

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

14:33 29 Jul 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

Illumina Earnings: What To Look For From ILMN

Illumina Earnings: What To Look For From ILMN Genomics company Illumina (NASDAQ:ILMN) will be announcing earnings results this Thursday after market close. Here's what to expect. Illumina beat analysts' revenue expectations last quarter, reporting revenues of $1.09 billion, up 4.8% year on year. It …

ILMN main company

Sharemaestro market context Trend signal active 52 weeks +87.5%

14:15 29 Jul 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

Labcorp (LH) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates

Wall Street analysts forecast that Labcorp Holdings (LH) will report quarterly earnings of $4.79 per share in its upcoming release, pointing to a year-over-year increase of 10.1%. It is anticipated that revenues will amount to $3.72 billion, exhibiting an increase of 5.4% compared to …

LH main company

Sharemaestro market context Trend signal active 52 weeks +15.6%

14:15 29 Jul 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

Insights Into Illumina (ILMN) Q2: Wall Street Projections for Key Metrics

In its upcoming report, Illumina (ILMN) is predicted by Wall Street analysts to post quarterly earnings of $1.23 per share, reflecting an increase of 3.4% compared to the same period last year. Revenues are forecasted to be $1.12 billion, representing a year-over-year increase of …

ILMN main company

Sharemaestro market context Trend signal active 52 weeks +87.5%

14:15 29 Jul 2026

finance.yahoo.com Earnings Main company 🇺🇸 United States

Unveiling Mettler-Toledo (MTD) Q2 Outlook: Wall Street Estimates for Key Metrics

Wall Street analysts expect Mettler-Toledo (MTD) to post quarterly earnings of $10.78 per share in its upcoming report, which indicates a year-over-year increase of 6.8%. Revenues are expected to be $1.03 billion, up 5% from the year-ago quarter. The consensus EPS estimate for the …

MTD main company

Sharemaestro market context Price above Trend Line 52 weeks +7.4% · Next-week setup positive 57.4%

14:11 29 Jul 2026

Simply Wall St Earnings Main company 🇺🇸 United States

Sotera Health (SHC) Could Be 12% Undervalued Following Warburg Pincus Exit

Sotera Health (SHC) is estimated to be 12% undervalued after private equity firm Warburg Pincus exited its stake, removing significant selling pressure. The company's fair value is projected at $20.22, with a discounted cash flow model suggesting an even higher value of $27.15 per …

SHC main company

Sharemaestro market context Trend signal active 52 weeks +15.0%

14:11 29 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

MGTX|MeiraGTx Holdings PLC|Price:11.810|Chg%:-0.490

MeiraGTx Holdings PLC (MGTX) has a high growth potential and relatively healthy fundamentals, with its valuation considered fairly valued within the Biotechnology & Medical Research industry. The company, a clinical-stage genetic medicines firm with several late-stage clinical programs, has shown strong revenue and profit …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

14:06 29 Jul 2026

BioSpace Market update Main company 🇺🇸 United States

Agilent Research Catalyst Award Presented to Eastern Institute of Technology, Ningbo

Agilent Technologies announced that the Eastern Institute of Technology, Ningbo, has received an Agilent Research Catalyst (ARC) Award, recognizing Professor Zongwei Cai's research into advanced analytical methods for detecting PFAS and other emerging environmental contaminants. The award provides funding and Agilent instrumentation, enabling Professor …

A main company

Sharemaestro market context Trend signal active 52 weeks +22.8% · Next-week setup negative 44.0%

14:01 29 Jul 2026

marketscreener.com Analyst action Main company 🇺🇸 United States

Baird Adjusts Price Target on IQVIA Holdings to $287 From $252, Maintains Outperform Rating

Baird has raised its price target for IQVIA Holdings (IQV) shares to $287 from $252, while reiterating an Outperform rating on the stock. This adjustment reflects an updated outlook on the company's valuation. IQVIA Holdings specializes in providing information, analytics, research, and healthcare services …

IQV main company

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

13:59 29 Jul 2026

Sharemaestro Market Watch Volume surge Main company 🇺🇸 United States

Quest Diagnostics Incorporated (DGX) draws heavier weekly trading as trend stays active

The healthcare diagnostics stock extended its weekly advance, with volume and momentum readings adding confirmation rather than contradiction.

DGX main company

Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1%

13:13 29 Jul 2026

Moomoo Analyst action Main company 🇺🇸 United States

Barclays Adjusts IQVIA Holdings Price Target to $275 From $210, Maintains Overweight Rating

Barclays has increased its price target for IQVIA Holdings (NYSE:IQV) to $275 from $210, while reiterating an Overweight rating on the stock. This adjustment indicates a positive outlook from Barclays regarding IQVIA's future stock performance.

IQV main company

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

13:07 29 Jul 2026

OpenSecrets Market update Main company 🇺🇸 United States

Danaher Corp Lobbyists, 2023

This OpenSecrets.org page details the lobbying activities of Danaher Corp in 2023. It lists 33 lobbyists, with 20 of them having prior federal government experience (revolving door). The page breaks down lobbyists by hiring firm, including Brownstein, Hyatt et al, Todd Strategy Group, Fulcrum …

DHR main company

Sharemaestro market context Price above Trend Line 52 weeks -3.7%

13:06 29 Jul 2026

Stock Titan Market update Main company 🇺🇸 United States

Ningbo Researchers Get Tools to Study PFAS and Potential Health Effects

Agilent Technologies has awarded an Agilent Research Catalyst (ARC) Award to Professor Zongwei Cai of the Eastern Institute of Technology, Ningbo. This award recognizes Professor Cai's pioneering research in developing advanced analytical methods for detecting PFAS and other emerging environmental contaminants. The funding and …

A main company

Sharemaestro market context Trend signal active 52 weeks +22.8% · Next-week setup negative 44.0%

13:00 29 Jul 2026

finance.yahoo.com Market update Main company 🇺🇸 United States

Xpress Genomics Joins Parse Biosciences’ Certified Service Provider Network

Stockholm-based service provider adds Evercode to its single cell sequencing offerings SEATTLE, July 29, 2026--(BUSINESS WIRE)--Parse Biosciences, the leading provider of scalable and accessible single cell sequencing, and a QIAGEN company, today announced that Xpress Genomics has joined its Certified Service Provider (CSP) program, …

QGEN main company

Sharemaestro market context Price above Trend Line 52 weeks -14.1%

12:38 29 Jul 2026

Moomoo Analyst action Main company 🇺🇸 United States

RBC Raises Price Target on IQVIA Holdings to $247 From $221, Keeps Outperform Rating

RBC Capital Markets has increased its price target for IQVIA Holdings (IQV) to $247, up from the previous $221. The firm has maintained its Outperform rating on the company's stock, indicating continued confidence in its performance. This adjustment suggests RBC's positive outlook on IQVIA …

IQV main company

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

12:12 29 Jul 2026

TradingKey Market update Main company 🇺🇸 United States

Qiagen NV (QGEN) Institutional Confidence

Qiagen NV (QGEN) has an institutional shareholding score of 7.00, placing it 80th out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 78.32%, a 4.59% increase quarter-over-quarter. ETHSX is the largest institutional shareholder, holding 980.90K shares, representing …

QGEN main company

Sharemaestro market context Price above Trend Line 52 weeks -14.1%

11:40 29 Jul 2026

News-Press NOW Regulatory and legal Main company 🇺🇸 United States

Actor and Cancer Advocate Patrick Dempsey Stars in Emotional Tribute Video From Guardant Health Memorializing Those Who Have Lost Their Lives to Colorectal Cancer

Guardant Health has launched an emotional tribute video featuring actor Patrick Dempsey to honor those who have died from colorectal cancer, a disease that claims over 55,000 American lives annually. The video underscores the critical need for screening, particularly with Guardant Health's innovative Shield™ …

GH main company

Sharemaestro market context Trend signal active 52 weeks +156.0%

11:40 29 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

BIOA|BIOAGE Labs Inc|Price:21.950|Chg%:+1.070

This article provides a comprehensive stock analysis of BIOAGE Labs Inc (BIOA) by TradingKey, highlighting its strong fundamentals, high growth potential, and "Buy" rating from analysts with a target price of $42.88. The company is in a growing phase, has high profit growth, and …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

11:40 29 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

Stock Score & Comprehensive Stock Analysis of Bioatla Inc (BCAB) - Tradingkey

This article provides a comprehensive stock analysis of Bioatla Inc (BCAB) by TradingKey, highlighting its relatively healthy fundamentals, high growth potential, and fair valuation within the Biotechnology & Medical Research industry. It notes strong institutional ownership and recent "Strong Buy" ratings from analysts, despite …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%

11:40 29 Jul 2026

TradingKey Analyst action Provider-linked mention 🇺🇸 United States

FLGT|Fulgent Genetics Inc|Price:19.941|Chg%:+0.301

This article provides a comprehensive stock analysis of Fulgent Genetics Inc (FLGT) by TradingKey. It highlights the company's relatively healthy fundamentals, significant growth potential, and fair valuation, positioning it 46th in the Healthcare Providers & Services industry. The analysis also notes high institutional ownership, …

DGX mentioned

Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1%

11:17 29 Jul 2026

GlobeNewswire Regulatory and legal Main company 🇺🇸 United States

GRAL Court Deadline: GRAIL, Inc. Investor Deadline in Securities Fraud Class Action is August 4 – Contact BFA Law if You Lost Money

Bleichmar Fonti & Auld LLP has announced a securities fraud class action lawsuit against GRAIL, Inc. (NASDAQ:GRAL) and its executives. The lawsuit alleges that GRAIL misled investors regarding its NHS-Galleri cancer trial, which caused a 50.55% stock drop on February 20, 2026, after the …

GRAL main company

Sharemaestro market context Price above Trend Line 52 weeks +98.2% · Next-week setup positive 61.9%

11:11 29 Jul 2026

TradingKey Earnings Provider-linked mention 🇺🇸 United States

FDMT|4D Molecular Therapeutics Inc|Price:10.060|Chg%:+0.450

This analysis of 4D Molecular Therapeutics Inc (FDMT) highlights its strong fundamentals, high growth potential, and fair valuation, with a "Buy" rating from multiple analysts and a target price of $28.22. The company, a late-stage biotechnology firm, is advancing therapies for retinal vascular diseases …

IQV mentioned

Sharemaestro market context Trend signal active 52 weeks +23.8% · Next-week setup negative 42.6%